Wedbush keeps Monte Rosa Therapeutics price target at $27.00
Wedbush maintained its $27.00 per-share price target for Monte Rosa Therapeutics, according to ratings actions cited (via TradingView News).
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.